Grant Program

 

The Fiscal Year 2023 cycle is now closed. Applications are still accepted on a rolling basis for the Literature Review Scholarship (Up to 5 awards).

All questions and inquiries should be directed to: mncctn@umn.edu.

Award Categories

Expand all

Literature Review Scholarship -Applications Open

Literature Review Scholarship

Full RFA Document

Application

This award aims to provide access to the scholarly journals and background materials needed in order to develop a research concept to begin to develop a protocol. MNCCTN will award up to 5 Literature Review Scholarships (Scholarship) on an ongoing and as needed basis to MNCCTN team members at our Partner and site locations (up to 3) or individuals at non-MNCCTN organizations that are providing clinical services serving Minnesotans (up to 2). The scholarship will provide the awardee with a 12 month “Person of Interest” account at the University of Minnesota which provides access to UMN Library resources. Library resources include online books and journals, in-person library access on all campuses, and research librarian assistance.
 

Application Requirements & Process

Research concepts must be cancer-related and can involve any point in the spectrum of cancer care including prevention, screening, cancer control, and survivorship. Applicants must be from MNCCTN Partner organizations or affiliated with an organization that provides cancer-related services and or care to Minnesotans and which does not provide access to comprehensive scholarly journals and resources.
 

Applications will open on February 1, 2022 and be reviewed and awarded on an on-going basis. No more than 5 awards will be awarded at any given time. Applications consist of: 

  • Letter of Interest (1 page max.)

    • Describe the cancer-related topic, protocol concept, research plan, and need for library access

    • Outline the short and long-term goals of the project

  • Letter of Support (1 page max.)

    • Demonstrating knowledge of and support for the protocol concept from either 

      • Applicant’s MNCCTN Operations Committee member or site Principal Investigator 

      • The applicant’s supervisor

  • Contact Information: Full name, address, phone number, date of birth, and email

For further details and information, view the full RFA document.

Discovery & Planning Grant- Applications Closed

Discovery & Planning Grant

Full RFA Document

This award offers funding  to develop a community-driven research concept by partnering with an identified community to learn about their most pressing cancer-related needs and working collaboratively with the community to develop potential strategies to address those needs. The completion of the project should result in a collaboratively developed research concept that could be pilot tested with the identified community. Successful projects may employ many strategies including local data collection, background research, and coalition building.

For the Fiscal Year 2023 funding cycle, up to two will be awarded, each with a maximum award amount of $15,000 per grant. This award is open to applicants of all MNCCTN clinical and research partners.
 

Proposal Requirements
 

  • Proposed projects must be cancer-related and based in Minnesota.
  • Proposed projects must identify intended community groups, organizations, or other stakeholders for the planning and outline a clear plan for meaningful engagement in the project including the development of the research concept.
  • Proposed projects must include a plan for sharing planning and project findings with key community partners and stakeholders.
  • Proposed projects will result in the development of a research concept that can be piloted with the identified community.
  • Proposed projects that are currently underway or are in the process of being funded will not be considered.

 

Application Process & Deadlines

Proposal Submission. Full proposals are due by April 29, 2022 at 5:00 PM. Proposals will be submitted electronically. Budgets must be submitted in the template provided in InfoReady. Applicants may submit only one concept proposal as the PI. There is no limit on the number of proposals for faculty as collaborators. The proposal may reference planned collaboration(s) with other institution(s); however, none of the awarded funds will be transferred to these institutions.

Proposals will be reviewed by members of the Masonic Cancer Center’s Community Impact Board who will make recommendations to the MNCCTN Steering Committee. The MNCCTN Steering Committee will make the final funding decision. All applicants will be notified of their funding status by June 20, 2022.

For more information on proposal requirements, timeline, review criteria, and more, view the full RFA document.

Community Site Awards- Applications Closed

Community Site Awards

These awards aim to broaden the depth and reach of clinical trials offered to cancer patients in Greater Minnesota. For Fiscal Year 2023 funding cycle, up to two grants will be awarded, each with a maximum award amount of $125,000 per grant. MNCCTN intends to award one grant in each version of the Community Site awards, but may award any combination of versions as applications warrant. Awardees will be expected to work in partnership with the MNCCTN HUB team on development and implementation of the study. Proposed trials should be written specifically to be implemented across all MNCCTN’s community sites in Minnesota.

  • Version A. Version A is open only to applicants from MNCCTN clinical partners. Clinical partners include Essentia Health, Sanford Health, Metro-Minnesota Community Oncology Research Consortium (MMCORC), Mayo Clinic Health System, and M Health Fairview. Please reach out to the HUB with any questions regarding whether you are eligible to apply for this version.
  • Version B. Version B is open to all MNCCTN partners; research or clinical.
    • Clinical partners as listed above.
    • Research partners are the Masonic Cancer Center, University of Minnesota, Mayo Clinic Cancer Center, and The Hormel Institute.

 

Proposal Requirements

  • Proposed projects must be cancer-related and interventional.
    • Both treatment interventional and non-treatment interventional trials will be considered
    • Data/specimen registries or observational only studies will not be considered
  • Proposed projects should not be oriented to site-specific operations to develop local administrative or logistical capabilities. Projects that could be considered Quality Improvement will not be funded.
  • Trials can involve any point in the spectrum of cancer care including prevention, screening, cancer control, and survivorship. Therapeutic trials proposed should be Phase 2 or Phase 3.
  • Proposed projects should consider and leverage the unique characteristics of MNCCTN and specifically enroll Greater Minnesota residents.
  • Projects that are currently enrolling or are in the process of being funded will not be considered.
  • Proposed projects are expected to be able to be implemented across all MNCCTN Partner sites. Single site or single Partner projects will not be considered regardless of any future broader implementation. Awardees are expected to work with sites to ensure the project can be implemented as broadly as possible across network sites.

 

Application Process & Deadlines

Letter of Intent. A letter of Intent (LOI) must be submitted electronically via InfoReady. Letters of Intent are mandatory and due by February 25, 2022 at 5:00 PM. Applicants may submit only one concept proposal as the PI. There is no limit on the number of proposals for faculty as collaborators. Applicants may not submit the same concept proposal to more than one funding mechanism. The LOI may reference planned collaboration(s) with other institution(s); however, none of the awarded funds will be transferred to these institutions. 

LOI will be reviewed by the MNCCTN HUB team. Invitations to submit full proposals will be sent by March 14, 2022.

For more information on proposal requirements, timeline, review criteria, and more, view the full RFA document.

Diversity, Equity, Inclusion & Justice (DEIJ) Award- Applications Closed

DEIJ Award

The DEIJ Award funds a research project that is designed to address the cancer burden in a population or community historically underrepresented in cancer clinical research within the state of Minnesota. This funding is intended for researchers, collaborations, clinical sites, etc. that already have a well-developed research idea and plan. For Fiscal Year 2023 one grant will be awarded, with a maximum award amount of $125,000.

The MNCCTN HUB Team is available to provide a variety of support to awardees and their study teams as needed. Awardees will be expected to work in partnership with the MNCCTN HUB team on development and implementation of the study as the project necessitates.

Applicants to this award are not required to be MNCCTN Partners. This RFA is open to current MNCCTN research and clinical partners as well as unaffiliated applicants. If an applicant would like to be paired with an academic investigator, please indicate so in the Letter of Intent.
 

Proposal Requirements

  • Proposed projects must be cancer-related and interventional.
    • Both treatment interventional and non-treatment interventional trials will be considered.
    • Data/specimen registries or observational only studies will not be considered.
  • Trials can involve any point in the spectrum of cancer care including prevention, screening, cancer control, and survivorship. Therapeutic trials proposed should be Phase 2 or Phase 3.
  • Projects must specifically a cancer burden in a population or community historically underrepresented in cancer clinical research.
  • Projects must take place within Minnesota and intend to recruit Minnesotan residents.
  • Projects funded by this award are not limited to a rural setting and do not have to open or be available to be open at current MNCCTN sites.
  • Projects that are currently enrolling or are in the process of being funded will not be considered.
  • Proposed projects should not be oriented to site-specific operations to develop local administrative or logistical capabilities.
  • Projects that could be considered Quality Improvement will not be funded.


Application Process & Timeline

Letter of Intent. A letter of Intent (LOI) must be submitted electronically via InfoReady. Letters of Intent are mandatory and due by February 25, 2022 at 5:00 PM. Applicants may submit only one concept proposal as the PI. There is no limit on the number of proposals for faculty as collaborators. Applicants may not submit the same concept proposal to more than one funding mechanism. The LOI may reference planned collaboration(s) with other institution(s); however, none of the awarded funds will be transferred to these institutions. 

LOIs will be reviewed by the MNCCTN HUB team. Invitations to submit full proposals will be sent by March 14, 2022.

For more information on proposal requirements, timeline, review criteria, and more, view the full RFA document.

Single Site Pilot Award- Applications Closed

Single Site Pilot Award

This award aims to develop a research concept specifically developed for, or originating from a community site from the planning and development through the piloting phase. Projects should have the intent to develop into a multi-site clinical trial and successful projects will be eligible for additional funding.

For the Fiscal Year 2023 funding cycle, up to one will be awarded with a maximum award amount of $50,000. This award is open to MNCCTN clinical partners only.

Proposal Requirements

  • Proposed projects must be cancer-related and interventional.
    • Both treatment interventional and non-treatment interventional trials will be considered
    • Data/specimen registries or observational only studies will not be considered
  • Proposed projects should not be oriented to site-specific operations to develop local administrative or logistical capabilities. Projects that could be considered Quality Improvement will not be funded.
  • Trials can involve any point in the spectrum of cancer care including prevention, screening, cancer control, and survivorship. Therapeutic trials proposed should be Phase 2 or Phase 3.
  • Proposed projects should consider and leverage the unique characteristics of MNCCTN and specifically enroll Greater Minnesota residents.
  • Projects that are currently enrolling or are in the process of being funded will not be considered.
  • Proposed projects are expected to be implemented at a single MNCCTN site, or across a single Partner’s sites only. Projects must be designed with the intention of future implementation network-wide.

 

Application Process & Deadlines

Letter of Intent. A letter of Intent (LOI) must be submitted electronically via InfoReady. Letters of Intent are mandatory and due by February 25, 2022 at 5:00 PM. Applicants may submit only one concept proposal as the PI. There is no limit on the number of proposals for faculty as collaborators. Applicants may not submit the same concept proposal to more than one funding mechanism. The LOI may reference planned collaboration(s) with other institution(s); however, none of the awarded funds will be transferred to these institutions.

LOIs will be reviewed by the MNCCTN HUB team. Invitations to submit full proposals will be sent by March 14, 2022.

For more information on proposal requirements, timeline, review criteria, and more, view the full RFA document.

Frequently Asked Questions

Expand all

How do I submit?

Except for the Literature Review award, all Letters of Intent and Applications will be entered through UMN's InfoReady system. The Literature Review application is via SmartSheets. Links to submit for each award are available in the award descriptions above.

Can I submit a study to enroll participants at X-site?

Maybe, but it depends on the award. Funding is available only for studies enrolling in Minnesota. Reach out to us for more information.

Who is eligible to apply?

Applications will be judged based on applicant experience and not on credentials. All qualified and appropriate applicants will be considered.

What has been funded in the past?

Three studies have been funded so far. More information on each study is available in the section below.

What does the grant actually pay for?

Depends on the grant, the full RFA documents for each award (linked in the award descriptions above) should explain this. If there are questions, reach out to us at mncctn@umn.edu.

This is exciting, but I'm not ready to submit this year, will these funds be available next year?

Awards will be offered semi-regularly, but some may not be offered every year.

For awards requiring collaboration with community partners, is there a definition for what this means?

Each RFA document has more information. No strict definition, but expectation is that these studies are community-driven and awards will be reviewed on the plan for the engagement of the community.

Are there definitions for what MNCCTN considers Diversity, Equity, Inclusion, or Justice focused?

Generally, this is considered by us to be those who are historically underrepresented in cancer clinical research. This is relatively broad, but the application should include significance of the study to the intended population.

My proposal might be considered quality Improvement or administrative in nature, what should I do?

Quality improvement or administrative-related studies will not be funded. If your idea is in a grey area, email us to discuss details at mncctn@umn.edu.

I have an idea but no idea how to write a protocol or set up a statistical design, what do I do?

Resources and support can be provided. Reach out to us at mncctn@umn.edu if this will be required.